Confluence Investment Management LLC increased its stake in shares of Alcentra Capital Corp. (NASDAQ:ABDC) by 0.8% during the second quarter, Holdings Channel reports. The fund owned 189,994 shares of the company’s stock after buying an additional 1,456 shares during the period. Confluence Investment Management LLC’s holdings in Alcentra Capital Corp. were worth $2,308,000 at the end of the most recent reporting period.
Separately, UBS Group AG boosted its position in Alcentra Capital Corp. by 3.9% in the first quarter. UBS Group AG now owns 187,480 shares of the company’s stock valued at $2,180,000 after buying an additional 6,975 shares during the last quarter. Institutional investors and hedge funds own 44.23% of the company’s stock.
Shares of Alcentra Capital Corp. (NASDAQ:ABDC) traded up 1.60% during mid-day trading on Tuesday, reaching $13.32. 96,014 shares of the company’s stock were exchanged. The company’s 50-day moving average price is $12.67 and its 200-day moving average price is $12.08. Alcentra Capital Corp. has a one year low of $8.87 and a one year high of $13.47.
Alcentra Capital Corp. (NASDAQ:ABDC) last posted its earnings results on Thursday, August 4th. The company reported $0.44 EPS for the quarter, beating analysts’ consensus estimates of $0.36 by $0.08. Alcentra Capital Corp. had a net margin of 18.31% and a return on equity of 10.83%. Analysts predict that Alcentra Capital Corp. will post $1.56 EPS for the current year.
The firm also recently announced a quarterly dividend, which will be paid on Thursday, October 6th. Shareholders of record on Friday, September 30th will be given a dividend of $0.34 per share. This represents a $1.36 dividend on an annualized basis and a yield of 10.21%. The ex-dividend date is Wednesday, September 28th. Alcentra Capital Corp.’s dividend payout ratio (DPR) is 266.67%.
ABDC has been the subject of several research reports. Janney Montgomery Scott initiated coverage on shares of Alcentra Capital Corp. in a report on Wednesday, June 22nd. They set a “neutral” rating and a $15.00 price objective for the company. TheStreet cut shares of Alcentra Capital Corp. from a “buy” rating to a “hold” rating in a report on Tuesday, July 5th.
In other news, insider David Scopelliti purchased 2,000 shares of the stock in a transaction dated Thursday, September 8th. The shares were acquired at an average cost of $12.88 per share, for a total transaction of $25,760.00. Following the acquisition, the insider now owns 4,600 shares of the company’s stock, valued at $59,248. The acquisition was disclosed in a legal filing with the SEC, which is available through this hyperlink. 4.47% of the stock is currently owned by insiders.
About Alcentra Capital Corp.
Alcentra Capital Corporation is a specialty finance company that operates as a non-diversified, closed-end management investment company. The Company operates as a business development company and a regulated investment company. It provides customized debt and equity financing solutions to lower middle-market companies, which are companies having annual earnings, before interest, taxes, depreciation and amortization of between $5 million and $15 million, and/or revenues of between $10 million and $100 million.
Want to see what other hedge funds are holding ABDC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Alcentra Capital Corp. (NASDAQ:ABDC).
Receive News & Ratings for Alcentra Capital Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alcentra Capital Corp. and related companies with MarketBeat.com's FREE daily email newsletter.